C125H143Cl6N39O9S4 — CID 161114653
1-[4-[5-chloro-4-(1-methylbenzimidazol-2-yl)pyrimidin-2-yl]piperazin-1-yl]-2-(dimethylamino)ethanone;N-[1-[5-chloro-4-(1-methylbenzimidazol-2-yl)pyrimidin-2-yl]piperidin-4-yl]methanesulfonamide;5-chloro-N-methyl-4-(1-methylbenzimidazol-2-yl)-N-(2-methylsulfonylethyl)pyrimidin-2-amine;2-[5-chloro-2-(4-methylpiperidin-1-yl)pyrimidin-4-yl]-1-methylbenzimidazole;2-[5-chloro-2-(4-methylsulfonylpiperidin-1-yl)pyrimidin-4-yl]-1-methylbenzimidazole;2-(5-chloro-2-piperidin-1-ylpyrimidin-4-yl)-1-methylbenzimidazole;N-[1-[4-(1-methylbenzimidazol-2-yl)pyrimidin-2-yl]piperidin-4-yl]methanesulfonamide (PubChem CID 161114653) has the molecular formula C125H143Cl6N39O9S4 and a molecular weight of 2676.77 g/mol. Its IUPAC name is 1-[4-[5-chloro-4-(1-methylbenzimidazol-2-yl)pyrimidin-2-yl]piperazin-1-yl]-2-(dimethylamino)ethanone;N-[1-[5-chloro-4-(1-methylbenzimidazol-2-yl)pyrimidin-2-yl]piperidin-4-yl]methanesulfonamide;5-chloro-N-methyl-4-(1-methylbenzimidazol-2-yl)-N-(2-methylsulfonylethyl)pyrimidin-2-amine;2-[5-chloro-2-(4-methylpiperidin-1-yl)pyrimidin-4-yl]-1-methylbenzimidazole;2-[5-chloro-2-(4-methylsulfonylpiperidin-1-yl)pyrimidin-4-yl]-1-methylbenzimidazole;2-(5-chloro-2-piperidin-1-ylpyrimidin-4-yl)-1-methylbenzimidazole;N-[1-[4-(1-methylbenzimidazol-2-yl)pyrimidin-2-yl]piperidin-4-yl]methanesulfonamide.
| Compound Name | 1-[4-[5-chloro-4-(1-methylbenzimidazol-2-yl)pyrimidin-2-yl]piperazin-1-yl]-2-(dimethylamino)ethanone;N-[1-[5-chloro-4-(1-methylbenzimidazol-2-yl)pyrimidin-2-yl]piperidin-4-yl]methanesulfonamide;5-chloro-N-methyl-4-(1-methylbenzimidazol-2-yl)-N-(2-methylsulfonylethyl)pyrimidin-2-amine;2-[5-chloro-2-(4-methylpiperidin-1-yl)pyrimidin-4-yl]-1-methylbenzimidazole;2-[5-chloro-2-(4-methylsulfonylpiperidin-1-yl)pyrimidin-4-yl]-1-methylbenzimidazole;2-(5-chloro-2-piperidin-1-ylpyrimidin-4-yl)-1-methylbenzimidazole;N-[1-[4-(1-methylbenzimidazol-2-yl)pyrimidin-2-yl]piperidin-4-yl]methanesulfonamide |
|---|---|
| PubChem CID | 161114653 |
| Molecular Formula | C125H143Cl6N39O9S4 |
| Molecular Weight | 2676.77 g/mol |
| Exact Mass | 2671.89 |
| IUPAC Name | 1-[4-[5-chloro-4-(1-methylbenzimidazol-2-yl)pyrimidin-2-yl]piperazin-1-yl]-2-(dimethylamino)ethanone;N-[1-[5-chloro-4-(1-methylbenzimidazol-2-yl)pyrimidin-2-yl]piperidin-4-yl]methanesulfonamide;5-chloro-N-methyl-4-(1-methylbenzimidazol-2-yl)-N-(2-methylsulfonylethyl)pyrimidin-2-amine;2-[5-chloro-2-(4-methylpiperidin-1-yl)pyrimidin-4-yl]-1-methylbenzimidazole;2-[5-chloro-2-(4-methylsulfonylpiperidin-1-yl)pyrimidin-4-yl]-1-methylbenzimidazole;2-(5-chloro-2-piperidin-1-ylpyrimidin-4-yl)-1-methylbenzimidazole;N-[1-[4-(1-methylbenzimidazol-2-yl)pyrimidin-2-yl]piperidin-4-yl]methanesulfonamide |
| SMILES | CC1CCN(c2ncc(Cl)c(-c3nc4ccccc4n3C)n2)CC1.CN(C)CC(=O)N1CCN(c2ncc(Cl)c(-c3nc4ccccc4n3C)n2)CC1.CN(CCS(C)(=O)=O)c1ncc(Cl)c(-c2nc3ccccc3n2C)n1.Cn1c(-c2ccnc(N3CCC(NS(C)(=O)=O)CC3)n2)nc2ccccc21.Cn1c(-c2nc(N3CCC(NS(C)(=O)=O)CC3)ncc2Cl)nc2ccccc21.Cn1c(-c2nc(N3CCC(S(C)(=O)=O)CC3)ncc2Cl)nc2ccccc21.Cn1c(-c2nc(N3CCCCC3)ncc2Cl)nc2ccccc21 |
| InChI | InChI=1S/C20H24ClN7O.C18H21ClN6O2S.C18H20ClN5O2S.C18H20ClN5.C18H22N6O2S.C17H18ClN5.C16H18ClN5O2S/c1-25(2)13-17(29)27-8-10-28(11-9-27)20-22-12-14(21)18(24-20)19-23-15-6-4-5-7-16(15)26(19)3;1-24-15-6-4-3-5-14(15)21-17(24)16-13(19)11-20-18(22-16)25-9-7-12(8-10-25)23-28(2,26)27;1-23-15-6-4-3-5-14(15)21-17(23)16-13(19)11-20-18(22-16)24-9-7-12(8-10-24)27(2,25)26;1-12-7-9-24(10-8-12)18-20-11-13(19)16(22-18)17-21-14-5-3-4-6-15(14)23(17)2;1-23-16-6-4-3-5-14(16)20-17(23)15-7-10-19-18(21-15)24-11-8-13(9-12-24)22-27(2,25)26;1-22-14-8-4-3-7-13(14)20-16(22)15-12(18)11-19-17(21-15)23-9-5-2-6-10-23;1-21(8-9-25(3,23)24)16-18-10-11(17)14(20-16)15-19-12-6-4-5-7-13(12)22(15)2/h4-7,12H,8-11,13H2,1-3H3;3-6,11-12,23H,7-10H2,1-2H3;3-6,11-12H,7-10H2,1-2H3;3-6,11-12H,7-10H2,1-2H3;3-7,10,13,22H,8-9,11-12H2,1-2H3;3-4,7-8,11H,2,5-6,9-10H2,1H3;4-7,10H,8-9H2,1-3H3 |
| InChIKey | UKDPNXZEUDRAFK-UHFFFAOYSA-N |
| XLogP | 18.10 |
| TPSA | 512.05 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 45 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 183 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2676.77 |
| LogP ≤ 5 | 18.10 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 45 |